What is the administration protocol for 10% dextrose (D10) solution in managing severe hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

D10 Formulation for Severe Hypoglycemia

For severe hypoglycemia, administer 10% dextrose (D10) as 5-gram aliquots (50 mL) repeated every 1-2 minutes until blood glucose exceeds 70 mg/dL, which provides equivalent efficacy to D50 with significantly lower post-treatment glucose levels and fewer adverse events. 1, 2

Composition and Dosing

  • D10 contains 0.1 grams of dextrose per mL (10 grams per 100 mL), meaning each 50 mL aliquot delivers 5 grams of glucose 3
  • Initial dose: 50-100 mL (5-10 grams) administered intravenously over 1-2 minutes 1, 4
  • Maximum total dose: 25 grams (250 mL) if needed, though most patients require only 10 grams 4, 2

Administration Protocol

Initial Treatment

  • Stop any insulin infusion immediately before administering dextrose 1
  • Administer 50 mL (5 grams) of D10 intravenously over 1-2 minutes 1, 2
  • Give through a small-bore needle into a large peripheral vein to minimize thrombosis risk 3, 1

Mandatory 15-Minute Recheck

  • Recheck blood glucose at exactly 15 minutes post-administration—this timing is critical as dextrose effects begin waning by 30 minutes 1
  • If glucose remains <70 mg/dL (or <100 mg/dL in neurologic injury patients), repeat with another 50 mL aliquot 1
  • Continue repeating 5-gram doses every 1-2 minutes until target achieved 1, 5

Ongoing Monitoring

  • Monitor blood glucose every 1-2 hours for patients on insulin infusions 1
  • Additional checks at 15 minutes and 60 minutes after hypoglycemia treatment 1

Clinical Advantages Over D50

Efficacy

  • Equivalent symptom resolution rates: D10 achieves 95.9% resolution versus 88.8% with D50 6
  • Median time to Glasgow Coma Scale of 15: 6-8 minutes for both concentrations 4, 2
  • Nearly complete hypoglycemia correction: 99.2% with D10 versus 98.7% with D50 6

Safety Profile

  • Zero adverse events reported with D10 (0/1057 patients) versus 13/310 with D50 6
  • Lower post-treatment glucose: 6.2 mmol/L (112 mg/dL) with D10 versus 9.4 mmol/L (169 mg/dL) with D50 6, 2
  • Reduced total dose required: median 10 grams with D10 versus 25 grams with D50 4, 2
  • No cardiac arrest or hyperkalemia risk associated with titrated D10 approach, unlike rapid D50 boluses 1, 5

Critical Safety Considerations

Avoid Overcorrection

  • Traditional 25-gram D50 boluses frequently cause hyperglycemia averaging 169 mg/dL, which is associated with worse outcomes 1, 5
  • Titrated 5-gram aliquots prevent overshoot while achieving symptom resolution 1, 5

Common Pitfalls to Avoid

  • Never delay the 15-minute recheck—hypoglycemia can recur as dextrose effects wane, especially with ongoing insulin action 1
  • Do not use D5 (5% dextrose) for acute hypoglycemia—it provides only 0.05 grams/mL and is insufficient for rapid correction 3
  • Administer slowly through large veins—rapid infusion through small peripheral veins increases thrombosis risk 3, 1
  • Do not use hypotonic maintenance fluids (D5 with 0.45% NaCl) for acute treatment—these are for prevention only 3

Alternative Formulations Context

When D10 is Unavailable

  • D50 can be diluted: Mix 50 mL of D50 with 200 mL sterile water to create 250 mL of D10 3
  • If using D50 directly: Give 10 mL (5 grams) aliquots rather than full 50 mL ampules 5, 7

Pediatric Considerations

  • Dose: 0.5 g/kg as 10% or 25% solution administered slowly 8
  • Avoid indiscriminate glucose administration—hyperglycemia worsens ischemic brain injury in children 8

Mortality Context

Severe hypoglycemia carries significant mortality risk (OR 3.233,95% CI 2.251-4.644), making prompt and appropriate treatment essential while avoiding the complications of overcorrection 1

References

Guideline

Management of Severe Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

D5 and D50 Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

D50 Ampule Dextrose Content and Hypoglycemia Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.